Abstract
Pharmacoeconomic analysis, defined as the description and analysis of the costs of drug therapy to health-care systems and society, will become a vital tool in making economic determinations for drug therapy. In a time when health-care costs continue to soar, the practical benefits of using a discipline such as pharmacoeconomics become evident. Managed care companies will use pharmacoeconomics as a tool to compare drugs that are clinically equal in safety and effectiveness. Institutions will be able to provide therapies with similar outcomes at more competitive prices. For example, a comparison of oral metronidazole to oral vancomycin, the standard of care for treating pseudomembranous colitis, provides the type of information required to perform such an analysis. A case can be made for metronidazole's use in the initial treatment of pseudomembranous colitis, as it is a less expensive agent with similar effectiveness as oral vancomycin. The techniques employed for pharmacoeconomics include cost-benefit analysis, cost-effectiveness analysis, cost-utility analysis, and quality-of-life analysis. A 10-step approach considers drug costs, hospitalization costs, efficacy, and relapse rates and provides an easy framework for constructing useful pharmacoeconomic models based upon the researcher's criteria.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.